{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:58:11Z","timestamp":1793735891811,"version":"4.6.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000319","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","award":["ARUK-RF2020A-010"],"award-info":[{"award-number":["ARUK-RF2020A-010"]}],"id":[{"id":"10.13039\/501100000319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Dementia with Lewy bodies (DLB), Parkinson\u2019s disease dementia (PDD), and Parkinson\u2019s disease (PD) collectively known as Lewy body diseases (LBDs) are neuropathologically characterised by \u03b1-synuclein deposits (Lewy bodies and Lewy neurites). However, LBDs also exhibit pathology associated with Alzheimer\u2019s disease (AD) (i.e. hyperphosphorylated tau and amyloid \u03b2 (A\u03b2). A\u03b2 can be deposited in the walls of blood vessels in the brains of individuals with AD, termed cerebral amyloid angiopathy (CAA). The aim of this study was to investigate the type and distribution of CAA in DLB, PDD, and PD and determine if this differs from AD. CAA type, severity,\u00a0and topographical distribution was assessed in 94 AD, 30 DLB, 17 PDD, and 11 PD cases, and\n                    <jats:italic>APOE<\/jats:italic>\n                    genotype evaluated in a subset of cases where available. 96.3% AD cases, 70% DLB cases and 82.4% PDD cases exhibited CAA (type 1 or type 2). However only 45.5% PD cases had CAA. Type 1 CAA accounted for 37.2% of AD cases, 10% of DLB cases, and 5.9% of PDD cases, and was not observed in PD cases. There was a hierarchical topographical distribution in regions affected by CAA where AD and DLB displayed the same distribution pattern that differed from PDD and PD.\n                    <jats:italic>APOE<\/jats:italic>\n                    \u03b54 was associated with severity of CAA in AD cases. Topographical patterns and severity of CAA in DLB more closely resembled AD rather than PDD, and as type 1 CAA is associated with clinical dementia in AD, further investigations are warranted into whether the increased presence of type 1 CAA in DLB compared to PDD are related to the onset of cognitive symptoms and is a distinguishing factor between LBDs. Possible alignment of the the topographical distribution of CAA and microbleeds in DLB warrants further investigation. CAA in DLB more closely resembles AD rather than PDD or PD, and should be taken into consideration when stratifying patients for clinical trials or designing disease modifying therapies.\n                  <\/jats:p>","DOI":"10.1186\/s40478-023-01714-7","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T10:03:09Z","timestamp":1707991389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8281-8938","authenticated-orcid":false,"given":"Lauren","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Attems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"issue":"4","key":"1714_CR1","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","volume":"18","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H et al (2008) Staging of neurofibrillary pathology in Alzheimer\u2019s disease: a study of the BrainNet Europe Consortium. Brain Pathol 18(4):484A496. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00147.x","journal-title":"Brain Pathol"},{"issue":"2","key":"1714_CR2","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ana.22112","volume":"69","author":"Z Arvanitakis","year":"2011","unstructured":"Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA (2011) Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol 69(2):320A327. https:\/\/doi.org\/10.1002\/ana.22112","journal-title":"Ann Neurol"},{"issue":"4","key":"1714_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00401-005-1074-9","volume":"110","author":"J Attems","year":"2005","unstructured":"Attems J (2005) Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol 110(4):345A359. https:\/\/doi.org\/10.1007\/s00401-005-1074-9","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1714_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00401-003-0796-9","volume":"107","author":"J Attems","year":"2004","unstructured":"Attems J, Jellinger KA (2004) Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathologyAa pilot study. Acta Neuropathol 107(2):83A90. https:\/\/doi.org\/10.1007\/s00401-003-0796-9","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1714_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00401-005-1064-y","volume":"110","author":"J Attems","year":"2005","unstructured":"Attems J, Jellinger KA, Lintner F (2005) Alzheimer\u2019s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol 110(3):222A231. https:\/\/doi.org\/10.1007\/s00401-005-1064-y","journal-title":"Acta Neuropathol"},{"issue":"10","key":"1714_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026609","volume":"6","author":"N Badiola","year":"2011","unstructured":"Badiola N, de Oliveira RM, Herrera F, Guardia-Laguarta C, Goncalves SA, Pera M et al (2011) Tau enhances alpha-synuclein aggregation and toxicity in cellular models of synucleinopathy. PLoS ONE 6(10):e26609. https:\/\/doi.org\/10.1371\/journal.pone.0026609","journal-title":"PLoS ONE"},{"issue":"22","key":"1714_CR7","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","volume":"85","author":"PA Boyle","year":"2015","unstructured":"Boyle PA, Yu L, Nag S, Leurgans S, Wilson RS, Bennett DA, Schneider JA (2015) Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology 85(22):1930A1936. https:\/\/doi.org\/10.1212\/WNL.0000000000002175","journal-title":"Neurology"},{"issue":"4","key":"1714_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112(4):389A404. https:\/\/doi.org\/10.1007\/s00401-006-0127-z","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1714_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197A211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"1714_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3233\/JAD-2009-1182","volume":"18","author":"C Brayne","year":"2009","unstructured":"Brayne C, Richardson K, Matthews FE, Fleming J, Hunter S, Xuereb JH et al (2009) Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based cambridge city over-75s cohort (CC75C) study. J Alzheimer\u2019s Dis 18:645A658. https:\/\/doi.org\/10.3233\/JAD-2009-1182","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"9","key":"1714_CR11","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/jnen\/59.9.768","volume":"59","author":"D Cadavid","year":"2000","unstructured":"Cadavid D, Mena H, Koeller K, Frommelt RA (2000) Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol 59(9):768A773. https:\/\/doi.org\/10.1093\/jnen\/59.9.768","journal-title":"J Neuropathol Exp Neurol"},{"issue":"8","key":"1714_CR12","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1161\/strokeaha.116.012999","volume":"47","author":"NF Case","year":"2016","unstructured":"Case NF, Charlton A, Zwiers A, Batool S, McCreary CR, Hogan DB et al (2016) Cerebral amyloid angiopathy is associated with executive dysfunction and mild cognitive impairment. Stroke 47(8):2010A2016. https:\/\/doi.org\/10.1161\/strokeaha.116.012999","journal-title":"Stroke"},{"issue":"2","key":"1714_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055848","volume":"8","author":"G Ciaccioli","year":"2013","unstructured":"Ciaccioli G, Martins A, Rodrigues C, Vieira H, Calado P (2013) A powerful yeast model to investigate the synergistic interaction of alpha-synuclein and tau in neurodegeneration. PLoS ONE 8(2):e55848. https:\/\/doi.org\/10.1371\/journal.pone.0055848","journal-title":"PLoS ONE"},{"issue":"21","key":"1714_CR14","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1523\/jneurosci.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM (2010) Synergistic interactions between abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 30(21):7281A7289. https:\/\/doi.org\/10.1523\/jneurosci.0490-10.2010","journal-title":"J Neurosci"},{"issue":"5123","key":"1714_CR15","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261(5123):921A923. https:\/\/doi.org\/10.1126\/science.8346443","journal-title":"Science"},{"issue":"5","key":"1714_CR16","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00415-020-09736-0","volume":"267","author":"PC Donaghy","year":"2020","unstructured":"Donaghy PC, Firbank M, Mitra D, Petrides G, Lloyd J, Barnett N et al (2020) Microbleeds in dementia with Lewy bodies. J Neurol 267(5):1491A1498. https:\/\/doi.org\/10.1007\/s00415-020-09736-0","journal-title":"J Neurol"},{"issue":"5","key":"1714_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.parkreldis.2014.02.012","volume":"20","author":"BN Dugger","year":"2014","unstructured":"Dugger BN, Adler CH, Shill HA, Caviness J, Jacobson S, Driver-Dunckley E, Beach TG (2014) Concomitant pathologies among a spectrum of parkinsonian disorders. Parkinsonism Relat Disord 20(5):525A529. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.02.012","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"1714_CR18","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","volume":"79","author":"P Edison","year":"2008","unstructured":"Edison P, Rowe CC, Rinne JO, Ng S, Ahmed I, Kemppainen N et al (2008) Amyloid load in Parkinson\u2019s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry 79(12):1331A1338. https:\/\/doi.org\/10.1136\/jnnp.2007.127878","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"1714_CR19","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1093\/brain\/awv229","volume":"138","author":"L Frings","year":"2015","unstructured":"Frings L, Hellwig S, Spehl TS, Bormann T, Buchert R, Vach W et al (2015) Asymmetries of amyloid-\u03b2 burden and neuronal dysfunction are positively correlated in Alzheimer\u2019s disease. Brain 138(10):3089A3099. https:\/\/doi.org\/10.1093\/brain\/awv229","journal-title":"Brain"},{"issue":"7","key":"1714_CR20","first-page":"35","volume":"88","author":"RV Geinisman","year":"1988","unstructured":"Geinisman RV, Oksova EE (1988) Morphologic diagnosis of vascular and senile dementia (the significance of Congophilic angiopathy). Zh Nevropatol Psikhiatr Im S S Korsakova 88(7):35A39","journal-title":"Zh Nevropatol Psikhiatr Im S S Korsakova"},{"issue":"5619","key":"1714_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"BI Giasson","year":"2003","unstructured":"Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT et al (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300(5619):636A640. https:\/\/doi.org\/10.1126\/science.1082324","journal-title":"Science"},{"issue":"4","key":"1714_CR22","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1212\/wnl.50.4.961","volume":"50","author":"SM Greenberg","year":"1998","unstructured":"Greenberg SM, Vonsattel JP, Segal AZ, Chiu RI, Clatworthy AE, Liao A et al (1998) Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology 50(4):961A965. https:\/\/doi.org\/10.1212\/wnl.50.4.961","journal-title":"Neurology"},{"issue":"9","key":"1714_CR23","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.parkreldis.2015.07.008","volume":"21","author":"I Gungor","year":"2015","unstructured":"Gungor I, Sarro L, Graff-Radford J, Zuk SM, Tosakulwong N, Przybelski SA et al (2015) Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer\u2019s disease. Parkinsonism Relat Disord 21(9):1101A1104. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.07.008","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"1714_CR24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00702-011-0641-6","volume":"118","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Song YJ, Harding AJ (2011) Striatal beta-amyloid in dementia with Lewy bodies but not Parkinson\u2019s disease. J Neural Transm 118(5):713A719. https:\/\/doi.org\/10.1007\/s00702-011-0641-6","journal-title":"J Neural Transm"},{"issue":"1","key":"1714_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/nan.12648","volume":"47","author":"D Hansen","year":"2021","unstructured":"Hansen D, Ling H, Lashley T, Foley J, Strand C, Eid T et al (2021) Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson\u2019s disease dementia. Neuropathol Appl Neurobiol 47(1):143A156. https:\/\/doi.org\/10.1111\/nan.12648","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"1714_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/s1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388A405. https:\/\/doi.org\/10.1016\/s1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"issue":"1","key":"1714_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX et al (2017) Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16(1):55A65. https:\/\/doi.org\/10.1016\/s1474-4422(16)30291-5","journal-title":"Lancet Neurol"},{"issue":"5A6","key":"1714_CR28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s007020200068","volume":"109","author":"KA Jellinger","year":"2002","unstructured":"Jellinger KA (2002) Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 109(5A6):813A836. https:\/\/doi.org\/10.1007\/s007020200068","journal-title":"J Neural Transm"},{"issue":"5","key":"1714_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00702-021-02345-9","volume":"128","author":"KA Jellinger","year":"2021","unstructured":"Jellinger KA (2021) Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases. J Neural Transm 128(5):687A699. https:\/\/doi.org\/10.1007\/s00702-021-02345-9","journal-title":"J Neural Transm"},{"issue":"3","key":"1714_CR30","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00702-007-0856-8","volume":"115","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA, Attems J (2008) Cerebral amyloid angiopathy in Lewy body disease. J Neural Transm (Vienna) 115(3):473A482. https:\/\/doi.org\/10.1007\/s00702-007-0856-8","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"1714_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00401-006-0088-2","volume":"112","author":"KA Jellinger","year":"2006","unstructured":"Jellinger KA, Attems J (2006) Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol 112(3):253A260. https:\/\/doi.org\/10.1007\/s00401-006-0088-2","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1714_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/ana.410240110","volume":"24","author":"CL Joachim","year":"1988","unstructured":"Joachim CL, Morris JH, Selkoe DJ (1988) Clinically diagnosed Alzheimer\u2019s disease: autopsy results in 150 cases. Ann Neurol 24(1):50A56. https:\/\/doi.org\/10.1002\/ana.410240110","journal-title":"Ann Neurol"},{"issue":"9","key":"1714_CR33","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3174\/ajnr.A4337","volume":"36","author":"SW Kim","year":"2015","unstructured":"Kim SW, Chung SJ, Oh YS, Yoon JH, Sunwoo MK, Hong JY et al (2015) Cerebral microbleeds in patients with dementia with lewy bodies and parkinson disease dementia. AJNR Am J Neuroradiol 36(9):1642A1647. https:\/\/doi.org\/10.3174\/ajnr.A4337","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"1714_CR34","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00702-015-1410-8","volume":"122","author":"A King","year":"2015","unstructured":"King A, Bodi I, Nolan M, Troakes C, Al-Sarraj S (2015) Assessment of the degree of asymmetry of pathological features in neurodegenerative diseases. What is the significance for brain banks? J Neural Transm 122(10):1499A1508. https:\/\/doi.org\/10.1007\/s00702-015-1410-8","journal-title":"J Neural Transm"},{"issue":"4","key":"1714_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000161560","volume":"26","author":"GG Kovacs","year":"2008","unstructured":"Kovacs GG, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Capellari S et al (2008) Mixed brain pathologies in dementia: the BrainNet Europe consortium experience. Dement Geriatr Cogn Disord 26(4):343A350. https:\/\/doi.org\/10.1159\/000161560","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"1714_CR36","first-page":"19","volume":"3","author":"S Love","year":"2014","unstructured":"Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K et al (2014) Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am J Neurodegener Dis 3(1):19A32","journal-title":"Am J Neurodegener Dis"},{"issue":"1","key":"1714_CR37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/jad-150241","volume":"49","author":"M M\u00e4kel\u00e4","year":"2016","unstructured":"M\u00e4kel\u00e4 M, Paetau A, Polvikoski T, Myllykangas L, Tanskanen M (2016) Capillary amyloid-\u03b2 protein deposition in a population-based study (Vantaa 85+). J Alzheimer\u2019s Dis 49(1):149A157. https:\/\/doi.org\/10.3233\/jad-150241","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"11","key":"1714_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000180","volume":"6","author":"FE Matthews","year":"2009","unstructured":"Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P (2009) Epidemiological pathology of dementia: attributable-risks at death in the medical research council cognitive function and ageing study. PLoS Med 6(11):e1000180. https:\/\/doi.org\/10.1371\/journal.pmed.1000180","journal-title":"PLoS Med"},{"issue":"7","key":"1714_CR39","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/nan.12664","volume":"46","author":"K McAleese","year":"2020","unstructured":"McAleese K, Walker L, Erskine D, Johnson M, Koss D, Thomas A, Attems J (2020) Concomitant LATE-NC in Alzheimer\u2019s disease is not associated with increased tau or amyloid-\u03b2 pathological burden. Neuropathol Appl Neurobiol 46(7):722A734. https:\/\/doi.org\/10.1111\/nan.12664","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7","key":"1714_CR40","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/alz.12291","volume":"17","author":"KE McAleese","year":"2021","unstructured":"McAleese KE, Colloby SJ, Thomas AJ, Al-Sarraj S, Ansorge O, Neal J et al (2021) Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia. Alzheimer\u2019s Dement 17(7):1121A1133. https:\/\/doi.org\/10.1002\/alz.12291","journal-title":"Alzheimer\u2019s Dement"},{"issue":"7","key":"1714_CR41","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/00005072-199907000-00005","volume":"58","author":"MO McCarron","year":"1999","unstructured":"McCarron MO, Nicoll JAR, Stewart J, Ironside JW, Mann DMA, Love S et al (1999) The apolipoprotein E \u22082 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol 58(7):711A718. https:\/\/doi.org\/10.1097\/00005072-199907000-00005","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"1714_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/wnl.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89(1):88A100. https:\/\/doi.org\/10.1212\/wnl.0000000000004058","journal-title":"Neurology"},{"issue":"7","key":"1714_CR43","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/wnl.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer\u2019s disease. Neurology 34(7):939A944. https:\/\/doi.org\/10.1212\/wnl.34.7.939","journal-title":"Neurology"},{"issue":"4","key":"1714_CR44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/wnl.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The consortium to establish a registry for Alzheimer\u2019s disease (CERAD) Part II standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41(4):479A486. https:\/\/doi.org\/10.1212\/wnl.41.4.479","journal-title":"Neurology"},{"key":"1714_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"T Montine","year":"2012","unstructured":"Montine T, Phelps C, Beach T, Bigio E, Cairns N, Dickson D et al (2012) National institute on Aging\u2013Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1A11. https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1714_CR46","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/ana.410410607","volume":"41","author":"JAR Nicoll","year":"1997","unstructured":"Nicoll JAR, Burnett C, Love S, Graham DI, Dewar D, Ironside JW et al (1997) High frequency of apolipoprotein E \u03f52 Allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 41(6):716A721. https:\/\/doi.org\/10.1002\/ana.410410607","journal-title":"Ann Neurol"},{"issue":"7","key":"1714_CR47","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1001\/archneur.1995.00540310076019","volume":"52","author":"JM Olichney","year":"1995","unstructured":"Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ (1995) Cerebral infarction in Alzheimer\u2019s disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 52(7):702A708. https:\/\/doi.org\/10.1001\/archneur.1995.00540310076019","journal-title":"Arch Neurol"},{"issue":"12","key":"1714_CR48","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1097\/00007611-198512000-00003","volume":"78","author":"JC Parker Jr","year":"1985","unstructured":"Parker JC Jr, Philpot J (1985) Postmortem evaluation of Alzheimer\u2019s disease. South Med J 78(12):1411A1413. https:\/\/doi.org\/10.1097\/00007611-198512000-00003","journal-title":"South Med J"},{"issue":"2","key":"1714_CR49","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1046\/j.1365-2990.2003.00424.x","volume":"29","author":"SD Preston","year":"2003","unstructured":"Preston SD, Steart PV, Wilkinson A, Nicoll JA, Weller RO (2003) Capillary and arterial cerebral amyloid angiopathy in Alzheimer\u2019s disease: defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol Appl Neurobiol 29(2):106A117. https:\/\/doi.org\/10.1046\/j.1365-2990.2003.00424.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"1714_CR50","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1750-3639.2009.00322.x","volume":"20","author":"V Soontornniyomkij","year":"2010","unstructured":"Soontornniyomkij V, Lynch MD, Mermash S, Pomakian J, Badkoobehi H, Clare R, Vinters HV (2010) Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy. Brain Pathol 20(2):459A467. https:\/\/doi.org\/10.1111\/j.1750-3639.2009.00322.x","journal-title":"Brain Pathol"},{"issue":"3","key":"1714_CR51","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00401-011-0936-6","volume":"123","author":"H Stefanits","year":"2012","unstructured":"Stefanits H, Budka H, Kovacs GG (2012) Asymmetry of neurodegenerative disease-related pathologies: a cautionary note. Acta Neuropathol 123(3):449A452. https:\/\/doi.org\/10.1007\/s00401-011-0936-6","journal-title":"Acta Neuropathol"},{"issue":"5","key":"1714_CR52","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90(5):1977A1981. https:\/\/doi.org\/10.1073\/pnas.90.5.1977","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1714_CR53","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3233\/jad-201495","volume":"80","author":"M Takemoto","year":"2021","unstructured":"Takemoto M, Yamashita T, Ohta Y, Tadokoro K, Omote Y, Morihara R, Abe K (2021) Cerebral microbleeds in patients with Parkinson\u2019s disease and dementia with lewy bodies: comparison using magnetic resonance imaging and 99 mTc-ECD SPECT subtraction imaging. J Alzheimer\u2019s Dis 80(1):331A335. https:\/\/doi.org\/10.3233\/jad-201495","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"3","key":"1714_CR54","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","volume":"61","author":"DR Thal","year":"2002","unstructured":"Thal DR, Ghebremedhin E, Rub U, Yamaguchi H, Del Tredici K, Braak H (2002) Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61(3):282A293. https:\/\/doi.org\/10.1093\/jnen\/61.3.282","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"1714_CR55","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58(12):1791A1800. https:\/\/doi.org\/10.1212\/WNL.58.12.1791","journal-title":"Neurology"},{"issue":"1","key":"1714_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-71305-2","volume":"10","author":"DX Thomas","year":"2020","unstructured":"Thomas DX, Bajaj S, McRae-McKee K, Hadjichrysanthou C, Anderson RM, Collinge J (2020) Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer\u2019s disease neuropathology. Sci Rep 10(1):1A9. https:\/\/doi.org\/10.1038\/s41598-020-71305-2","journal-title":"Sci Rep"},{"issue":"2","key":"1714_CR57","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neulet.2003.08.048","volume":"352","author":"J Tian","year":"2003","unstructured":"Tian J, Shi J, Bailey K, Mann DM (2003) Negative association between amyloid plaques and cerebral amyloid angiopathy in Alzheimer\u2019s disease. Neurosci Lett 352(2):137A140. https:\/\/doi.org\/10.1016\/j.neulet.2003.08.048","journal-title":"Neurosci Lett"},{"issue":"3","key":"1714_CR58","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","volume":"131","author":"JB Toledo","year":"2016","unstructured":"Toledo JB, Gopal P, Raible K, Irwin DJ, Brettschneider J, Sedor S et al (2016) Pathological \u03b1-synuclein distribution in subjects with coincident Alzheimer\u2019s and Lewy body pathology. Acta Neuropathol 131(3):393A409. https:\/\/doi.org\/10.1007\/s00401-015-1526-9","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1714_CR59","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/01.str.14.6.924","volume":"14","author":"HV Vinters","year":"1983","unstructured":"Vinters HV, Gilbert JJ (1983) Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14(6):924A928. https:\/\/doi.org\/10.1161\/01.str.14.6.924","journal-title":"Stroke"},{"issue":"5","key":"1714_CR60","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ana.410300503","volume":"30","author":"JP Vonsattel","year":"1991","unstructured":"Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr (1991) Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 30(5):637A649. https:\/\/doi.org\/10.1002\/ana.410300503","journal-title":"Ann Neurol"},{"issue":"5","key":"1714_CR61","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","volume":"129","author":"L Walker","year":"2015","unstructured":"Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C et al (2015) Neuropathologically mixed Alzheimer\u2019s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol 129(5):729A748. https:\/\/doi.org\/10.1007\/s00401-015-1406-3","journal-title":"Acta Neuropathol"},{"key":"1714_CR62","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14698","author":"L Walker","year":"2019","unstructured":"Walker L, Stefanis L, Attems J (2019) Clinical and neuropathological differences between Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies current issues and future directions. J Neurochem. https:\/\/doi.org\/10.1111\/jnc.14698","journal-title":"J Neurochem"},{"issue":"1","key":"1714_CR63","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3233\/jad-150890","volume":"52","author":"L Xiong","year":"2016","unstructured":"Xiong L, Davidsdottir S, Reijmer YD, Shoamanesh A, Roongpiboonsopit D, Thanprasertsuk S et al (2016) Cognitive profile and its association with neuroimaging markers of non-demented cerebral amyloid angiopathy patients in a stroke unit. J Alzheimer\u2019s Dis 52(1):171A178. https:\/\/doi.org\/10.3233\/jad-150890","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"1","key":"1714_CR64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00401-003-0706-1","volume":"106","author":"D Xu","year":"2003","unstructured":"Xu D, Yang C, Wang L (2003) Cerebral amyloid angiopathy in aged Chinese: a clinico-neuropathological study. Acta Neuropathol 106(1):89A91. https:\/\/doi.org\/10.1007\/s00401-003-0706-1","journal-title":"Acta Neuropathol"},{"issue":"9","key":"1714_CR65","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.parkreldis.2015.06.019","volume":"21","author":"K Yamashiro","year":"2015","unstructured":"Yamashiro K, Tanaka R, Hoshino Y, Hatano T, Nishioka K, Hattori N (2015) The prevalence and risk factors of cerebral microbleeds in patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 21(9):1076A1081. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.06.019","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"1714_CR66","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1016\/j.neurobiolaging.2015.08.008","volume":"36","author":"L Yu","year":"2015","unstructured":"Yu L, Boyle PA, Nag S, Leurgans S, Buchman AS, Wilson RS et al (2015) APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging 36(11):2946A2953. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.08.008","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1714_CR67","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00401-003-0738-6","volume":"106","author":"D Zekry","year":"2003","unstructured":"Zekry D, Duyckaerts C, Belmin J, Geoffre C, Moulias R, Hauw JJ (2003) Cerebral amyloid angiopathy in the elderly: vessel walls changes and relationship with dementia. Acta Neuropathol 106(4):367A373. https:\/\/doi.org\/10.1007\/s00401-003-0738-6","journal-title":"Acta Neuropathol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-023-01714-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T03:11:44Z","timestamp":1708312304000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-023-01714-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1714"],"URL":"https:\/\/doi.org\/10.1186\/s40478-023-01714-7","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Brain tissue was obtained at autopsy and stored within the Newcastle Brain Tissue Resource (NBTR) in accordance with Newcastle University Ethics Board (The Joint Ethics Committee of Newcastle and North Tyneside Health Authority, reference: 08\/H0906\/136).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}